H2O2 Safety
The Food & Drug Administration (FDA) in Federal Regulation Vol. 46, Number 6, Jan 9, 1981, in effect gave the food industry a green light to use hydrogen peroxide in the “Aseptic” packaging process. The FDA has further ruled that hydrogen peroxide can be used in the processing of cheese and related cheese products (part 133), eggs and egg products (part 160), and as an anti-microbial agent in whey processing. They have also ruled it to be used in cleaning and healing mouth injuries and as a mouthwash (1% to 3% food grade H2O2).
As previously stated, “The International Agency for Research on Cancer (IARC) has determined that hydrogen peroxide is not classifiable as to its carcinogencity to humans. Even though accusations against H2O2 have been wide spread, there is no verified data, in man, that H2O2 in any way causes or promotes cancer in vivo.” The WHO-IARC said, “There is inadequate evidence in humans for the carcinogenicity of hydrogen peroxide.”
Information from the Hazardous Substances Data Bank (HSDB), a database of the National Library of Medicine’s TOXNET system (http://toxnet.nlm.nih.gov) indicates in general, ingestion, ocular or dermal exposure to small amounts of dilute hydrogen peroxide will cause no serious problems.
In 5 persons who accidentally drank 50 mL of a 33% H2O2 solution (not the readily available 3%), symptoms included stomach and chest pain, retention of breath, foaming at the mouth and loss of consciousness. Later, motor and sensory disorders, fever, micro-hemorrhages and moderate leukocytosis were noted. Still, all recovered completely within 2-3 weeks. 159 Yet, it may rarely be the cause of accidental death. 160
A review by Howes found a total of 13 deaths due to the accidental or intentional use of H2O2 in the entire history of recorded medical literature available on the internet. 16
Compare the record of safety with hydrogen peroxide with that of pharmaceutical drugs, which kill 12 per hour, every hour of the day, for 365 days a year (106,000/year). A 2000 report published in the Journal of the American Medical Association by Barbara Starfield, M.D., MPH reported that drugs kill over 106,000 annually, as a conservative estimate. 161
Pravda has discussed the possible role of hydrogen peroxide in the induction of ulcerative colitis secondary to non-physiological concentrations of peroxide used in peroxide enemas. 162
Caveat: Some references do not provide access to the original article or to an abstract. Most of the references available to Howes on the internet do not go beyond 1979. Thus, there may be cases of which I am unaware. Many of the articles concerning ingestion or infusion of peroxide are non-conclusive. Clinical histories are incomplete and documentation is scanty. One thing for certain is that many cases of over-zealous or accidental ingestion of concentrated hydrogen peroxide (20-40%) have had a surprisingly uneventful recovery. Actually, the ingestion or infusion of 3% H2O2 has resulted in very few patients who developed serious complications or severe outcomes.
A retrospective review of all exposures reported to a regional poison center over a 36 month period and found that of 95,052 exposures reported, 325 (.34%) were due to hydrogen peroxide. The pediatric population (< 18 years) accounted for 71% of hydrogen peroxide exposures and ingestion was the most common route of exposure (83%). Nausea and vomiting were the most common symptoms secondary to ingestion. Ocular and dermal exposures to dilute solutions resulted in transient symptoms without permanent sequelae. While most exposures by all routes resulted in a benign outcome (no effect or minor effect), there was a trend toward more severe outcomes in those who ingested a concentration greater than 10% (p = 0.011). 163 (Division of Emergency Medicine, University of Utah School of Medicine, Utah Poison Control Center, Salt Lake City).
Reports have described levels of H2O2 over 50 M as being cytotoxic for a wide range of plants and animal cells in vitro, but is dependent upon many factors such as, pH, media used, cell type used, length of exposure, etc. Paradoxically, acatalasemia in humans appears to produce no significant phenotype, nor does “knockout” of glutathione peroxidase in mice except under conditions of “abnormally high oxidative stress.” This is contrary to the teachings of the free radical theory and consistent with Howes’ Unified Theory. 164
Discussion
It is important to reemphasize the fact that antioxidants have repeatedly failed to prevent, control or reverse cancer and a host of so-called oxidative stress diseases. Thus, the free radical theory lacks predictability and consequently, according to the scientific method, it is unfounded. It is inexcusable that researchers continue to incriminate EMODs as only deleterious, noxious or mutagenic agents. In vitro studies may have little resemblance to the events occurring in living/breathing cells, which have considerable EMOD levels omnipresent.
Previously, investigators suggested that anything which served as an antioxidant was good and anything which oxidized something else was bad. That has repeatedly been proven to be untrue. All antioxidants can serve as prooxidants of greater or lesser reactivity. Further, H2O2 is now well recognized as an important and widespread second messenger for all aerobic cells. Based on scientific investigations, implying or giving the false impression that the presence of H2O2 is categorically bad is another example of unfounded and erroneous reporting.
Rethinking the Free Radical Theory
Any critical evaluation of EMODs must address the misconceptions propagated by the free radical theory of oxidative stress and aging. Hard data has yielded the following: 15
high levels of the antioxidant bilirubin cause kernicterus and permanent brain damage
the antioxidant β-carotene increases the rate of lung cancer development in smokers
the antioxidant CoQ, ubiquinone, when deleted from the diet of C. elegans, increases its lifespan
SOD/catalase mimetics decrease the lifespan of house flies
the antioxidant α-tocopherol, vitamin E, increases the rate and number of heart attacks and strokes
high levels of the antioxidant, uric acid, cause gout and cardiovascular disease
acatalasemic patients live basically normal lives
Many molecules are designed to accept and receive electrons as a natural part of their reactivity, especially the transitions metals and the heme proteins. Oxygen’s various modified derivatives, electronic configurations and states, are the primary agents that protect us from infections and neoplastic growths throughout our lives, from conception to death. Report after report shows that mitochondria play a crucial role in apoptosis. 165
A growing body of evidence favors the involvement of intracellular reactive oxygen species (EMODs) at some point during apoptotic execution. 166-170 Apoptosis is carried out by a multistage chain of reactions in which EMODs act as triggers and essential mediators. 171, 172 The level of lipid peroxidation in patients with cancer was significantly reduced compare with that in healthy control subjects. 173 The lower level of lipid peroxidation in the cancer patients may be indicative of low EMOD levels, which would allow for the development of cancer.
Even death signaling by anticancer drugs generally relies on positive input from the mitochondria, as is evidenced by the resistance of tumor cells over-expressing the death-inhibitory protein Bcl-2 that is localized to the membranes of mitochondria, endoplasmic reticulum, and nucleus. 174-176 Repeatedly, the critical role of cellular redox status in the regulation of death signaling has been demonstrated. 177-180
These findings become more important considering the critical role of the mitochondria during apoptosis and the fact that mitochondria have been implicated directly as a prime source of EMODs during drug-induced apoptosis. 181-183 As the mitochondria are a major source of intracellular EMODs, it is tempting to speculate that EMODs, such as H2O2, may function both upstream and downstream of the mitochondria. Tumor cells lacking Bax (Bax–/–) are resistant to the effect of some anti-cancer drugs. 184
Analysis of subcellular distribution of Bax (in HCT116, HL60, and CEM cells) revealed that Bax redistributed to the mitochondrial fraction from the cytosol on exposure to H2O2, which could be significantly blocked by the H2O2 scavenger, catalase.
Recruitment of Bax to the mitochondria during apoptotic signaling has been linked to the activation of upstream caspase 8 and caspase 8-mediated cleavage of the proapoptotic protein Bid. This is particularly true on ligation of death receptors, such as CD95 (Apo1/Fas). Additionally, H2O2 and anticancer drugs have been shown to up-regulate the expression of the CD95 receptor or its ligand (CD95L) in some systems. 185, 186
Investigators utilized the ability of certain anticancer drugs to increase intracellular production of EMODs, specifically H2O2. 187 Indeed, exposure of HCT116 Bax+/– or HL60 cells to a novel anticancer compound C1 resulted in an increase in intracellular H2O2 and translocation of Bax to the mitochondria. This translocation of Bax was inhibited by catalase, thus establishing the critical role of intracellular H2O2 in mitochondrial recruitment during drug-induced apoptosis of tumor cells. These data indicate that Bax translocation triggered in tumor cells during drug (C1)-induced apoptosis was a direct result of intracellular H2O2 production, independent of the upstream caspase 8 or ceramide pathways. 187
Cytosolic Acidification
Cytosolic acidification is an early event in apoptosis and provides an intracellular milieu permissive for efficient death execution. In this regard, exposure of cells to H2O2 or drugs that trigger intracellular increase in H2O2 results in a significant drop in cytosolic pH. 187
Accordingly, signals that inhibit apoptotic acidification impede death signaling as demonstrated in a recent study. 188 Investigators results provided strong evidence that the link between H2O2 and Bax translocation could be the drop in cytosolic pH brought about by exposure of cells to exogenous H2O2 or endogenous production of H2O2 on drug exposure. It is possible that this indicates the pivotal role of H2O2 in cancer cell killing or apoptotic execution.
This shows that apoptosis is likely initiated with EMOD production, especially H2O2. H2O2 is, for the most part, essential for cancer killing and a shift to an acidic intracellular environment may also aid in its tumoricidal activity and the production of other agents within the EMOD family. Studies demonstrated the ability of commonly used chemotherapeutic drugs vincristine and daunorubicin to trigger an early increase in intracellular H2O2. 188
Pro-oxidant intracellular milieu is a hallmark of many tumor cells and is believed to endow tumor cells with a survival advantage over their normal counterparts. 189, 190 It has been shown previously that maintaining a slightly elevated intracellular O2 - promotes cellular proliferation 135 and inhibits apoptotic signaling. 191 Fortunately, this is one specific feature which provides us with an opportunity to selectively kill cancer cells by increasing EMOD levels even further.
Many investigators have demonstrated the critical role of intracellular H2O2 in rendering the cytosolic milieu permissive for efficient apoptotic execution. 169, 170, 192 Further, these data strongly support and underscore the critical role of H2O2 in creating a permissive intracellular milieu for efficient drug-induced execution of tumor cells. 193
Dicumarol Increased EMODs Killing Human Pancreatic Cancer Cells
Dicumarol is a naturally occurring anticoagulant derived from coumarin that induces cytotoxicity and oxidative stress in human pancreatic cancer cells. Dicumarol
increased intracellular levels of superoxide (O2 -. ), as measured by hydroethidine staining, and inhibited cell growth. 194 Mitochondrial production of EMODs mediates the increased susceptibility of cancer cells to dicumarol-induced cytotoxicity. 195
MnSOD Overexpression and Inhibition of H2O2 Removal Increases Cancer Cell Cytotoxicity
Overexpression of manganese superoxide dismutase (MnSOD) and inhibition of H2O2 removal, increases cancer cell cytotoxicity. Investigators hypothesized that increasing endogenous O2 .- production in cells that were pretreated with adenoviral MnSOD (AdMnSOD) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) would lead to an increased level of intracellular H2O2 accumulation and increased cell killing. The cytotoxic effects of Adriamycin or radiation, agents known to produce O2 .-, were determined in MDA-MB-231 breast cancer cells pretreated with AdMnSOD plus BCNU both in vitro and in vivo. In vitro, AdMnSOD plus BCNU sensitized cells to the cytotoxicity of Adriamycin or radiation. In vivo, AdMnSOD, BCNU, and Adriamycin or ionizing radiation inhibited tumor growth and prolonged survival. Thus, agents that produce O2 .- in combination with AdMnSOD plus BCNU may represent a powerful new antitumor regimen against breast cancer. 196
Myeloperoxidase Involvement in H2O2-induced Apoptosis of HL-60 Human Leukemia Cells
Investigators examined the mechanism of H2O2-induced cytotoxicity and its relationship to oxidation in human leukemia cells. The HL-60 promyelocytic leukemia cell line was sensitive to H2O2, and at concentrations up to about 20-25 uM, the killing was mediated by apoptosis. When HL-60 cells were incubated with methimazole or 4-aminobenzoic acid hydrazide, which are inhibitors of myeloperoxidase, they no longer underwent H2O2-induced apoptosis. 197 This strongly supports the primary role of EMOD induced apoptosis in cancer cell cytotoxicity.
Antitumor Therapy via Enzymatic Generation of Hydrogen Peroxide
Investigators studied the antitumor activity of an H2O2-generating enzyme, D-amino acid oxidase (DAO), and its conjugate with polyethylene glycol (PEG; PEG-DAO). To generate cytotoxic H2O2 at the tumor site, PEG-DAO was first administrated i.v. to tumor-bearing mice. After an adequate lag time, the substrate of DAO, D-proline, was injected i.p. This treatment resulted in significant suppression of tumor growth.
PEG-DAO thus delivered together with D-proline produces remarkable antitumor activity via extensive generation of H2O2. 198
SOD Over Expression Increases Peroxide Levels and Suppresses Human Prostate Cancer Cells
Investigators studied the role of the antioxidant enzyme manganese superoxide dismutase (MnSOD) in androgen-independent human prostate cancer (PC-3) cells' growth rate in vitro and in vivo. Production of extracellular H2O2 was increased in the MnSOD-overexpressing clones. Results are consistent with MnSOD being a tumor suppressor gene in human prostate cancer. 199
This supports the assertion that prooxidant EMODs, such as H2O2, contribute to a continually functional oxidative protective system to curtail cancer growth. The increased SOD resulted in increased peroxide levels, which in turn suppressed tumor growth, via EMOD induced apoptosis.
Increased EMODs Increases Cancer Cell Cytotoxicity
Relative to normal cells, neoplastic cells demonstrate increased sensitivity to glucose-deprivation-induced cytotoxicity. To determine whether oxidative stress mediated by O2 .- and hydroperoxides contributed to the differential susceptibility of human epithelial cancer cells to glucose deprivation, the oxidation of DHE (dihydroethidine; for O2 .- ) and CDCFH(2) [5- (and 6-)carboxy-2',7'-dichlorodihydrofluorescein diacetate; for hydroperoxides] was measured in human colon and breast cancer cells (HT29, HCT116, SW480 and MB231) and compared with that in normal human cells [FHC cells, 33Co cells and HMECs (human mammary epithelial cells)]. HCT116 and MB231 cells were more susceptible to glucose-deprivation-induced cytotoxicity and oxidative stress, relative to 33Co cells and HMECs. HT29 cells were also more susceptible to 2DG (2-deoxyglucose)-induced cytotoxicity, relative to FHC cells. Overexpression of manganese SOD (superoxide dismutase) and mitochondrially targeted catalase significantly protected HCT116 and MB231 cells from glucose-deprivation-induced cytotoxicity and oxidative stress and also protected HT29 cells from 2DG-induced cytotoxicity. These results show that cancer cells (relative to normal cells) demonstrate increased steady-state levels of EMODs (reactive oxygen species; i.e. O2 .- and H2O2 ) that contribute to differential susceptibility to glucose-deprivation-induced cytotoxicity and oxidative stress. These studies support the hypotheses that cancer cells increase glucose metabolism to compensate for excess metabolic production of EMODs and that inhibition of glucose and hydroperoxide metabolism may provide a biochemical target for selectively enhancing cytotoxicity and oxidative stress in human cancer cells. 200
EMODs are Positive Signals in the Fruit Fly Immune System
The September 24, 2009 issue of the journal Nature, carried an article by Dr. Utpal Banerjee et al, UCLA’s Jonsson Comprehensive Cancer Center researchers found much to their surprise, that in Drosophila, the common fruit fly, moderately elevated levels of EMODs are a good thing. Banerjee said, “These small molecules act as an internal communicator, signaling certain blood precursor cells, or blood stem cells, to differentiate into immune-bolstering cells in reaction to a threat. After the progenitor cells differentiate, the EMOD levels return to normal, ensuring the safety and survival of the mature blood cells.”
Thus, he asks, “could excessive use of antioxidants deplete our immune systems?” Alleged;y, reducing levels of reactive oxygen is usually the goal, and what Banerjee found was surprising, in that when EMODs were taken away from the blood stem cells, they failed to differentiate into the immune-bolstering cells, called macrophages. On the other hand, when levels of EMODs were further increased by genetic means, the blood stem cells “differentiated like gang busters,” Banerjee said, making a large number of macrophages.
The EMODs, Banerjee said, acted as a signaling mechanism that kept the blood stem cells in a certain state - when levels rose, it was a message to the cell to differentiate. Keeping their EMOD levels slightly elevated puts the cells on alert, sensitized and ready to respond to any threat quickly.
That work prompted the obvious question: If fruit fly blood stem cells and mammalian blood stem cells operate in the same way, is it a good thing for people to be taking antioxidants? Are antioxidants dulling the immune system and its ability to react to threats? It is interesting, however, that these types of blood progenitors in mammals also give rise to macrophages, Banerjee said.
Banerjee said, “If we find that those blood stem cells aren't primed to respond because the ROS levels are reduced, that would not be a good thing. Our findings raise the possibility that wanton overdose of antioxidant products may in fact inhibit formation of cells participating in innate immune response.” Once again, this data emphasizes the crucial role of EMODs in aerobic cells. http://www.medicalnewstoday.com/articles/165268.php Accessed 9-25-09.
Just to Add Further Complications
Pro-senescent Effect of Hydrogen Peroxide on Cancer Cells and Tumor Suppression
Mild oxidative stress is known to induce premature senescence, termed stress-induced premature senescence (SIPS), in normal human diploid cells. Investigators determined whether mild oxidative stress would trigger SIPS in a human tumor cell line, human lung adenocarcinoma A549. The results showed that sublethal concentrations of H2O2 induced SIPS in A549 cells and consequently attenuated, but did not completely eliminate, the tumorigenicity of these cells. They next investigated the reasons for this incomplete impairment of tumorigenicity in A549 cells in SIPS. The results suggested that H2O2 treated A549 cells are composed of a heterogeneous cell population: one is sensitive to H2O2 and the other is resistant or undergoes reversal; the latter reverted to their original tumorigenic form. The molecular mechanisms determining the cellular fate of tumor cells in SIPS should be identified in order to make use of SIPS and oncogene-induced senescence in tumor cells as methods of tumor suppression. 201
Indirect Evidence for EMOD Induced Apoptosis Via Antioxidant Studies
The US is experiencing epidemics of cancer, diabetes, obesity and fatigue, which may be related to increased ingestion of antioxidant vitamins and dietary supplements, which are now commonly found as supplements or fortifiers of many foods and are aggressively marketed to an ever-growing segment of the population. These agents could be interfering with or modifying our continually operational prooxidant protective system.
Despite two decades of controversy regarding the use of dietary antioxidant supplementation during conventional chemotherapy and radiation therapy, questions remain about their efficacy and safety. However, on the basis of published randomized clinical trials, the use of supplemental antioxidants during chemotherapy and radiation therapy should be discouraged because of the possibility of tumor protection and reduced patient survival. 202
Several new reports are raising concerns about the safety and efficacy of vitamin and mineral supplements in healthy individuals and cancer patients and survivors. Some experts see a need for further studies; whereas, others say that there are sufficient negative data to stop vitamin trials altogether. 203
Significant in vitro data exists showing that antioxidants can block EMOD-induced apoptosis for a wide variety of cancerous cell types, such as leukemia, lymphoma, retinoblastoma, myeloma, pheochromocytoma and human cancers of the breast, lung, pancreas, liver, colon, rectum and endometrium. 204 This data can not be ignored.
However, it has recently been shown that EMODs may have an alternative activity, by modulating tumor cell signaling and that tumor cell signaling mediated by EMODs are readily reversible upon treatment with antioxidants. This emerging evidence may serve as bona fide signal transduction modifiers for cancer. A re-examination is warranted. 205
However, in the words of one investigator, “If you suppress free radicals, you suppress programmed cell death.” 206
One Final Note
Philipp Niethammer, Harvard Medical School postdoctoral researcher and biologist, accidentally discovered while analyzing the severed tail of zebrafish that the hydrogen peroxide in their wounds appeared in bursts at the wound about 17 minutes before the leukocytes that were supposed to be producing them appeared too. On 6-4-09, ScienceNow reported that hydrogen peroxide summons reinforcements from the immune system, and more specifically white blood cells, which in turn aid with the healing process. Please view the video of peroxide migration in the wound of a zebrafish http://www.youtube.com/watch?v=a7PJ8yXyPVU. “Hydrogen peroxide marshals immune system.” Accessed 10-9-09. This interesting video illustrates the rapid wound response and permeability of H2O2.
However, due to the complex nature of the interactions of EMODs and antioxidants within the body, it is difficult to clearly and definitively interpret the results of many experiments and observations.
Conclusion
Unarguably, EMODs are intricately, inextricably and crucially involved in cancer cell killing via their prominent role in apoptosis. Statements of the ineffectiveness in the killing of cancerous cells via hydrogen peroxide or other EMOD types are baseless, inaccurate and irresponsible. The lingering inaccuracies of the free radical theory must be countered by the obvious omnipresent and ubiquitous known salutary effects of the prooxidant EMODs. Their presence in steady state quantities testifies to their essential nature in healthy homeostasis and their low toxicity. EMODs, and especially hydrogen peroxide, are produced throughout the body in steady state levels on an as needed and when needed basis and serve to support the interrelated highly complex redox systems of the body. It is inconceivable that they only exist for pernicious purposes. Because of their relatively short half lives, their localized instantaneous concentrations can remain at low levels. Yet, their synthesis and availability can be called upon at any given moment to combat impending pathogens or neoplasia.
EMODs have bactericidal, fungicidal, virucidal and anti-protozoan and anti-neoplastic roles but also have far reaching cellular signaling control functions. The peroxide spike during the respiratory burst classically serves as a protective role against infectious pathogens, as does EMOD induced apoptosis to combat neoplasia. Hydrogen peroxide is likely the most ubiquitous member of the family of EMOD agents. Its important and prominent biochemical role is ever expanding.
References
1. Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46.
2. Howes M.D., PhD., R. (2007). Antioxidant Vitamins A, C & E; Death in Small Doses and Legal Liability? PHILICA.COM Article number 89. Published April 5, 2007.
3. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 11: 298–300, 1956.
4. Harman, D., 1981. The aging process. Proc. Natl Acad. Sci. USA 78, 7124–7128.
5. Beckman, K.B., Ames, B.N., 1998. The free radical theory of aging matures. Physiol. Rev. 78, 547–581.
6. Finkel, T., Holbrook, N.J., 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408, 239–247.
7. Balaban, R.S., Nemoto, S., Finkel, T., 2005. Mitochondria, oxidants, and aging. Cell 120, 483–495.
8. Marnett LJ, Riggins JN, West JD. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest. 2003; 111: 583–593.
9. Darley-Usmar, V., Starke-Reed, P.E., 2000. Antioxidants: strategies for interventions in aging and age-related diseases, a workshop sponsored by the National Institute on aging and by the office of dietary supplements. Antioxid. Redox. Signal. 2, 375–377.
10. Howes R.M. The Free Radical Fantasy: A Panoply of Paradoxes. Ann. N. Y. Acad. Sci. 2006;1067:22-26.
11. Chance B, Sies, H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
12. Hydrogen Peroxide: A Signaling Messenger. James R. Stone, Suping Yang. Antioxidants & Redox Signaling. March/April 2006, 8(3-4): 243-270.
13. Howes, R. M. U.T.O.P.I.A. - Unified Theory of Oxygen Participation in Aerobiosis. © 2004. Free Radical Publishing Co. Kentwood, LA, available at www.iwillfindthecure.org.
14. Halliwell B. Oxidants and human disease: some concepts. FASEB J. 1987;1:358–364.
15. Howes, R.M. © 2005. The Medical and Scientific Significance of Oxygen Free Radical Metabolism. Free Radical Publishing Co. Kentwood, LA. available at www.iwillfindthecure.org.
16. Howes, R.M. Hydrogen Peroxide Monograph 1: Scientific, Medical and Biochemical Overview & Monograph 2: Antioxidant Vitamins A, C, & E: Equivocal Scientific Studies, © 2006. Free Radical Publishing Co. Kentwood, LA. available at www.iwillfindthecure.org.
17. Marie Csete. Oxygen in the Cultivation of Stem Cells. Ann. N.Y. Acad. Sci. 1049: 1–8 (2005.
18. Go YM, Gipp JJ, Mulcahy RT, and Jones DP. H2O2-dependent activation of GCLC-ARE4 reporter occurs by mitogen-activated protein kinase pathways without oxidation of cellular glutathione or thioredoxin-1. J Biol Chem 279: 5837–5845, 2004.
19. Aitken J, Fisher H. Reactive oxygen species generation and human spermatozoa: the balance of benefit and risk. Bioessays. 1994 Apr;16(4):259-67.
20. Acker H, Bolling B, Delpiano MA, Dufau E, Gorlach A & Holtermann G (1992). The meaning of H2O2 generation in carotid body cells for pO2 chemoreception. Journal of the Autonomic Nervous System, 41: 41-51.
21. Lisa Melton. The antioxidant myth: a medical fairy tale – from New Scientist. http://www.newscientist.com/article/mg19125631.500.html (5 August 2006) New Scientist. Pg. 40-43. volume 191; issue 2563.
22. B.M. Barbior. Superoxide: a two-edged sword. Braz J Med Biol Res, February 1997, Volume 30(2) 141-155.
23. Thannical VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1005-L1028.
24. Eaton JW, Qian M. Molecular basis of cellular iron toxicity. Free Radic Biol Med 2002; 32: 833-840.
25. Harman, D. 1957. Prolongation of the normal life span by radiation protection chemicals. J. Gerontol. 12: 257-263.
26. Boveris A, Cadenas E. Mitochondrial production of hydrogen peroxide regulation by nitric oxide and the role of ubisemiquinone. IUBMB Life 2000; 50: 245-250.
27. Eberhardt MK. Reactive Oxygen Metabolites: Chemistry and Medical Consequences. CRC Press 2001.
28. Chen S, Schopfer P. Hydroxyl radical production in physiological reactions. Eur J Biochem 1999; 260: 726-735.
29. Fridovich I. Oxygen toxicity: A radical explanation. J Exp Biol 1998; 20: 1203-1209.
30. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000; 29:222-230.
31. Lemasters J, Nieminen A. Mitochondria in Pathogenesis. Kluwer Academic/Plenum Publishers 2001: 281-286) 90.
32. St-Pierre, J., Buckingham, J.A., Roebuck, S.J. and Brand, M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 2002; 277:44784-44790.
33. Rhee SG, Bae YS, Lee SR, Kwon J: Hydrogen peroxide: A key messenger that modulates protein phosphorylation through cysteine oxidation. Science’s stke. Available at: www.stke.sciencemag.org/cgi/content/full/OC_sigtrans; 2000/53/pe1.
34. Rhee SG: Redox signaling: Hydrogen peroxide as intracellular messenger. Exp Mol Med 31: 53–59, 1999.
35. Finkel T: Oxygen radicals and signaling. Curr Opin Cell Biol 10: 248–253, 1998.
36. Suzuki YJ, Ford GD: Redox regulation of signal transduction in cardiac and smooth muscle. J Mol Cell Cardiol 31: 345–353, 1999.
37. Radia Forteza et al. Regulated Hydrogen Peroxide Production by Duox in Human Airway Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology. Vol. 32, pp. 462-469, 2005.
38. Ramachandran S, Morris SM, Devamanoharan P, Henein M, Varma SD. Radio-isotopic determination of hydrogen peroxide in aqueous humor and urine. Exp Eye Res. 1991 Oct;53(4):503-6.
39. García-Castiñeiras S. Hydrogen peroxide in the aqueous humor: 1992-1997. P R Health Sci J. 1998 Dec;17(4):335-43.
40. Niki L. Reynaert et al. Catalase Overexpression Fails to Attenuate Allergic Airways Disease in the Mouse. The Journal of Immunology, 2007, 178: 3814-3821.
41. Li JM and Shah AM. (2002) Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 277:19952–19960.
42. Grandvaux N, Grizot S, Vignais PV, Dagher MC. (1999) The Ku70 autoantigen interacts with p40phox in B lymphocytes. J Cell Sci 112:Pt 4503–513.
43. IARC, 1985). (IARC. 1985. International Agency for Research on Cancer. Hydrogen Peroxide. In: IARC Monographs on the Evaluation of Carcinogenic Risk if Chemicals to Humans: Allyl compounds, Aldehydes, Epoxides and Peroxides, Vol. 36. IARC, Lyon, pp. 285-314.
44. Krippeit-Drews, P., Lang, F., Haussinger, D. and Drews, G. Pflugers. H2O2 induced hyperpolarization of pancreatic -cells. Pflügers Arch. 426: 552-554, 1994.
45. Krippeit-Drews, P., Kramer, C., Welker, S., Lang, F., Ammon, H.P. and Drews, G. Interference of H2O2 with stimulus-secretion coupling in mouse pancreatic β-cells. J Physiol (Lond) 1999; 514(Pt 2): 471-481.
46. Livingston J, Gurny P, Lockwood D: Insulin-like effects of polyamines in fat cells. Mediation by H2O2 formation. J Biol Chem 1977, 252:560-562.
47. Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biology & Medicine. 1996;20:463–466.
48. Anna Yu Bogdanova and Mikko Nikinmaa. Reactive Oxygen Species Regulate Oxygen-sensitive Potassium Flux in Rainbow Trout Erythrocytes. The Journal of General Physiology, Volume 117, Number 2, February 1, 2001 181-190.
49. Halliwell B. Reactive oxygen species and the nervous system. 1992. J. Neurochemistry 59, 1609-1623.
50. C Giulivi, P Hochstein, KJ Davies. Hydrogen peroxide production by red blood cells. Free Radic Biol Med (1994) 16: 123-9.
51. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44-84.
52. Akos Koller and Zsolt Bagi. Nitric oxide and H2O2 contribute to reactive dilation of isolated coronary arterioles. Am J Physiol Heart Circ Physiol 287: H2461-H2467, 2004.
53. Balachandran P and Govindarajan R. Cancer—an ayurvedic perspective Pharmacol Res 2005; 51: 19–30.
54. Papa S and Shulachev VP. Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 1997; 174: 305–19.
55. Matsuzawa A, Ichijo H. Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid Redox Signal. 2005;7:472–481.
56. Han H, Wang H, Long H, Nattel S, Wang Z. Oxidative preconditioning and apoptosis in L-cells. Roles of protein kinase B and mitogen-activated protein kinases. J Biol Chem. 2001;276:26357–26364.
57. Reinehr R, Becker S, Eberle A, Grether-Beck S, Haussinger D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem. 2005; 280(29):27179-27194.
58. Senturker, S., Tschirret-Guth, R., Morrow, J., Levine, R. and Shacter, E. Induction of apoptosis by chemotherapeutic drugs without generation of reactive oxygen species. Arch of Biochem and Biophy 2002; 397(2): 262-272.
59. J H. Doroshow. Role of Hydrogen Peroxide and Hydroxyl Radical Formation in the Killing of Ehrlich Tumor Cells by Anticancer Quinones. PNAS June 15, 1986, vol. 83, no. 12, 4514-4518.
60. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90: 889–905 .
61. Ochsner M (1997) Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B 39: 1–18 .
62. Fisher A. M. R., Murphree A. L., Gomer C. J. Clinical, and preclinical photodynamic therapy. Lasers Surg. Med., 17: 2-31, 1995.
63. Henderson B. W., Dougherty T. J. How does photodynamic therapy work? Photochem. Photobiol., 55: 145-157, 1992.
64. Oleinick N. L., Evans H. E. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res., 150: S146-S156, 1998.
65. Luna M. C., Wong S., Gomer C. J. Photodynamic therapy mediated induction of early response genes. Cancer Res., 53: 1374-1380, 1994.
66. Gollnick S. O., Liu X., Owczarczak B., Musser D., Henderson B. W. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res., 57: 3904-3909, 1997.
67. Tao J-S., Sanghera J. S., Pelech S. L., Wong G., Levy J. G. Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative. J. Biol. Chem., 271: 27107-27115, 1996.
68. Gomer C. J., Luna M., Ferrario A., Rucker N. Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation. Photochem. Photobiol., 53: 275-279, 1991.
69. Gomer C. J., Ferrario A., Rucker N., Wong S., Lee A. Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization. Cancer Res., 51: 6574-6579, 1991.
70. Gomer C., Ryter S., Ferrario A., Rucker N., Wong S., Fisher A. Photodynamic therapy mediated oxidative stress can induce heat shock proteins. Cancer Res., 56: 2355-2360, 1996.
71. Curry P. M., Levy J. Stress protein expression in murine tumor cells following photodynamic therapy with benzoporphyrin derivative. Photochem. Photobiol., 58: 374-379, 1993.
72. Price M, Terlecky SR, Kessel D. A Role for Hydrogen Peroxide in the Pro-apoptotic Effects of Photodynamic Therapy. Photochem Photobiol. 2009 Jul 21.
73. Chekulayeva LV, Shevchuk IN, Chekulayev VA, Ilmarinen K. Hydrogen peroxide, superoxide, and hydroxyl radicals are involved in the phototoxic action of hematoporphyrin derivative against tumor cells. J Environ Pathol Toxicol Oncol. 2006;25(1-2):51-77.
74. Redmond RW, Gamlin JN. A compilation of singlet oxygen yields from biologically relevant molecules. Photochem. Photobiol. 1999;70:391–475.
75. Dysart JS, Patterson MS. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Phys. Med. Biol. 2005;50:2597–2616.
76. Buettner GR, Need MJ. Hydrogen peroxide and hydroxyl free radical production by hematoporphyrin derivative, ascorbate and light. Cancer Lett. 1985;25:297–304.
77. Galina G. Kramarenko, Stephen G. Hummel, Sean M. Martin, and Garry R. Buettner. Ascorbate Reacts with Singlet Oxygen to Produce Hydrogen Peroxide. Photochem Photobiol. 2006; 82(6): 1634–1637.
78. Henry Jay Forman. Hydrogen Peroxide: The Good, The Bad, and The Ugly. Contained in: Oxidants in Biology. Springer Netherlands. ISBN 978-1-4020-8398-3. 2008.
79. James R. Stone, Suping Yang. Hydrogen Peroxide: A Signaling Messenger. Antioxidants & Redox Signaling. March/April 2006, 8(3-4): 243-270.
80. Babior, B.M. NADPH oxidase: An update. Blood 1999; 93: 1464-1476.
81. Bayraktutan, U., Blayney, L. and Shah, A.M. Molecular characterization and localization of the NADPH oxidase components gp91-phox and p22-phox in endothelia cells. Arterioscler Thromb Vasc Biol 2000; 20: 1903-1911.
82. Goossens, V., Grooten, J., DeVos, K. and Fiers. W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 1995; 92: 8115-8119.
83. Finkel, T. Redox-dependent signal transduction. FEBS Lett 2000; 476: 52-54.
84. Trembovler, V., Abu-Raya, S. and Shohami, E. Synergism between tumor necrosis factor-alpha and H2O2 enhances cell damage in rat PC12 cells. Neurosci Lett. 2003 Dec 19; 353(2):115-118.
85. Hohler, B.; Holzapfel, B., and Kummer W. NADPH oxidase submits and superoxide production in porcine pulmonary artery endothelial cells. Histochem Cell Biol 2000; 114: 29-37.
86. Rueckschloss, U. Galle, J., Zerkowski H. R. and Morawietz, H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 2001; 104: 1767-1772.
87. Signal Transduction by reactive Oxygen and Nitrogen Species: Pathways and Chemical Principles. Edited by H.J. Forman, J. Fukuto and M. Torres, Kluwer Academic Publishers, 2003.
88. Schafer, F. Q. and Buettner, G. R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30: 1191-1212.
89. Hoidal, J.R. Reactive oxygen species and cell signaling. Am J Respir Cell Mol Biol 2001; 25: 661-663.
90. Schreck, R., Rieber, P. and Baeuerle, P.A. Reactive oxygen intermediates as apparently widely needed messengers in the activation of the NK-k B transcription factor and HIV-1. Embo J 1991; 10: 2247-2258.
91. Sen, C.K. and Packer, L. Antioxidant and redox regulation of gene transcription. Faseb J 1996; 10: 709-720.
92. Allen, R.G. and Tresini, M. Oxidative stress and gene regulation. Free Rad Biol Med 2000; 28: 463-499.
93. Los, M., W. Droege, K. Stricker, P. A. Baeuerle, K. Schulze-Osthoff. 1995. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol. 25:159.
94. Harlan, J. M., K. S. Callahan. 1984. Role of hydrogen peroxide in the neutrophil-mediated release of prostacyclin from cultured endothelial cells. J. Clin. Invest. 74:442.
95. Lewis, M. S., R. E. Whatley, P. Cain, T. M. McIntyre, S. M. Prescott, G. A. Zimmerman. 1988. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J. Clin. Invest. 82:2045.
96. Sundaresan, M., Z-X. Yu, V. J. Ferrans, K. Irony, T. Finkel. 1995. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270:296.
97. Rao, G. N., B. C. Berk. 1992. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 70:593.
98. Griendling, K.K. and Ushio-Fukai, M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 2000; 91: 21-27.
99. Patel, R.P., Moellering, D., Murphy-Uhrich, J., Jo., H., Beckman, S. and Darley-Usmar, V.M. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radic Biol Med 2000; 28: 1780-1794.
100. Forman, H.J. and Torres, M. Signaling by the respiratory burst in macrophages. IUBMB Life 2001; 51: 365-371.
101. Warburg, O. On the origin of cancer cells. Science 1956; 123: 309-314.
102. Einar K. Rofstad, Heidi Rasmussen, Kanthi Galappathi, Berit Mathiesen, Kristin Nilsen and Bjørn A. Graff. Hypoxia Promotes Lymph Node Metastasis in Human Melanoma Xenografts by Up-Regulating the Urokinase-Type Plasminogen Activator Receptor. Cancer Research 62, 1847-1853, March 15, 2002.
103. Hickman, J.A. Apoptosis induced by anticancer drugs. Cancer Metast Rev 1992; 11: 121-139.
104. Reinehr R, Becker S, Eberle A, Grether-Beck S, Haussinger D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem. 2005; 280(29):27179-27194.
105. Yokomizo A, Ono M, Nanri H, Makino Y, Ohga T, Wada M, Okamoto T, Yodoi J, Kuwano M, Kohno K. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res 1995;55:4293–4296.
106. Hasinoff B. B., Davey J. P. Adriamycin and its iron(III) and copper(III) complexes, glutathione-induced dissociation, cytochrome c oxidase inactivation and protection: binding to cardiolipin. Biochem. Pharmacol., 37: 3663-3669, 1988.
107. Burger R. M. Cleavage of nucleic acids by bleomycin. Chem. Rev., 98: 1153-1169, 1998.
108. Byfield J. E., Lee Y. C., Tu L., Kullhanian F. Molecular interactions of the combined effects of bleomycin and X-rays on mammalian cell survival. Cancer Res., 36: 1138-1143, 1976.
109. Sangeetha, P., Das, U.N., Koratkar, R. and Suryaprabha, P. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med 1990; 8(1): 15-19.
110. Ferlini C, Scambia G, Marone M, Distefano M, Gaggini C, Ferrandina G, Fattorossi A, Isola G, Benedetti Panici P, Mancuso S. Tamoxifen induces oxidative stress and apoptosis in estrogen receptor-negative human cancer cell lines. Br J Cancer 1999;79:257–263.
111. P. Vaupel and L. Harrison. Tumor Hypoxia: Causative Factors, Compensatory Mechanisms, and Cellular Response. Oncologist, November 1, 2004; 9(suppl_5): 4 – 9.
112. Loughlin KR; Manson K; Cragnale D; Wilson L; Ball RA; Bridges KR. The use of hydrogen peroxide to enhance the efficacy of doxorubicin hydrochloride in a murine bladder tumor cell line J Urol. 2001; 165(4):1300-4.
113. Lionel Resnick, Harold Rabinovitz, David Binninger, Maria Marchetti, Herbert Weissbach. Topical sulindac combined with hydrogen peroxide in the treatment of actinic keratoses. Journal of Drugs in Dermatology. January 1, 2009. Volume: 8 Issue: 1 Page: 29(4).
114. Aronoff, B.L. Regional oxygenation in neoplasms. Cancer 1965; 18: 1250.
115. Mallams, J.T., Balla, G.A. and Finney, J.W. Regional oxygenation and irradiation in the treatment of malignant tumors. Prog in Clin Cancer 1965; 1: 137.
116. Nathan, C. F., and R. K. Root. 1977. Hydrogen peroxide release from mouse peritoneal macrophages. Dependence on sequential activation and triggering.]. Exp. Med. 146:1648.
117. Nathan CF, Cohn ZA. Antitumor effects of hydrogen peroxide in vivo. J Exp Med. 1981 Nov 1;154(5):1539–1553.
118. Mallams, J.T., Balla, G.A. and Finney, J.W. Regional oxygenation and irradiation in the treatment of malignant tumors. Prog Clin Cancer 1965; 1: 137.
119. Finney, J.W., Collier, R.E., Balla, G.A., Tomme, J.W., Wakley, J., Race, G.J., Urschel, H.C., D’Errico, A.D. and Mallams, J.T. The preferential localization of radioisotopes in malignant tissue by regional oxygenation. Nature 1961; 202: 1172.
120. Finney, J.W., Balla, G.A., Collier, R.E., Wakely, J., Urschel, H.C. and Mallams, J.T. Differential localization of isotopes in tumors through the use of intra-arterial hydrogen peroxide: Part 1: Basic science. Amer J Roentgen 1965; 94: 783.
121. Nathan, C. F., L, H. Brukner, S. C. Silverstein, and Z. A. Cohn. 1979. Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J. Exp. Med. 149:84.
122. Philpott, G. W., W. T. Shearer, R. J. Bower, and C. W. Parker. 1973. Selective cytotoxicity of hapten-substituted cells with an antibody-enzyme conjugate. J. Immunol. 111:921.
123. Edelson, P. J., and Z. A. Cohn. 1973. Peroxidase-mediated mammalian cell cytotoxicity. J. Exp. Med. 138:318.
124. Clark, R. A., S. J. Klebanoff, A. B. Einstein, and A. Fefer. 1975. Peroxidase-H20-halide system: cytotoxic effect on mammalian tumor cells. Blood. 45:161.
125. Nathan, C. F. 1979. The role of oxidative metabolism in the cytotoxicity of activated macrophages after pharmacologic triggering. In Immunobiology and Immunotherapy of Cancer. W. D. Terry and Y. Yamamura, editors. Elsevier North-Holland, Inc., New York. 59.
126. Philpott, G. W., A. Kulczycki, Jr., E. H. Grass, and C. W. Parker. 1980. Selective binding and cytotoxicity of rat basophilic leukemia cells (RBL-1) with immunoglobulin E-biotin and avidin-glucose oxidase conjugates.J. Immunol. 125:1201.
127. Nathan, C. F., B. A. Arrick, H. W. Murray, N. M. DeSantis, and Z. A. Cohn. 1981. Tumor cell antioxidant defenses: inhibition of the glutathione redox cycle enhances macrophage mediated cytolysis.J. Exp. Med. 153:766.
128. Nathan CF, Brukner LH, Silverstein SC, Cohn ZA. Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J Exp Med. 1979 Jan 1;149(1):84–99.
129. Nathan CF, Silverstein SC, Brukner LH, Cohn ZA. Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J Exp Med. 1979 Jan 1;149(1):100–113.
130. Keilin, D., and E. F. Hartree. 1948. Properties of glucose oxidase (notatin). Biochem. J. 42:221.
131. Filep, J.G., Lapierre, C., Lachance, S. and Chan, J.S.D. Nitric oxide cooperates with hydrogen peroxide in inducing DNA fragmentation and cell lysis in murine lymphoma cells. Biochem J 1997; 321: 887-901.
132. Kanner, J., Harel, S. and Granit, R. Arch Biochem Biophys 1991; 289: 130-136.
133. Noronha-Dutra, A.A., Epperlein, M.M. and Woolf, N. FEBS Lett 1993; 321: 59-62.
134. Burdon R. H., Gill V., Rice-Evans C. Cell proliferation and oxidative stress. Free Radic. Res. Commun., 7: 149-159, 1989.
135. Burdon R. H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med., 18: 775-794, 1995.
136. Takeuchi,T., Matsugo,S. and Morimoto,K. (1997) Mutagenicity of oxidative DNA damage in Chinese hamster V79 cells. Carcinogenesis, 18, 2051–2055.
137. Yin Y, Solomon G, Deng C, Barrett JC. Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress. Mol Carcinog 1999;24:15–24.
138. Huang, et al, Tumor promotion by hydrogen peroxide in rat liver epithelial cells. Carcinogenesis, Vol. 20, No. 3, pp. 485-492, 1999.
139. Dizdaroglu, M. (1993) In DNA and Free Radicals (Halliwell, B., and Aruoma, O.I. eds.), pp. 19-39, Ellis Horwood, Chichester.
140. Halliwell, B. and Aruoma, O.I. DNA damage by oxygen-derived species. (1991) FEBS Lett. 281, 9-19.
141. L.J. Marnett. Oxyradicals and DNA damage. Carcinogenesis 2000 Mar;21(3):361-70.
142. Turrens, J.F. Mitochondrial formation of reactive oxygen species. (2003) Journal of Physiology-LONDON 552(2):335-344.
143. Campian, J.L., Qian, M., Gao, X., and Eaton, J.W. Oxygen tolerance and coupling of mitochondrial electron transport. 279(45): 46580-46587, 2004.
144. Riordan N, Riordan H and Casiari J. Clinical and experimental experiences with intravenous vitamin C. Journal of Orthomolecular Medicine, Special Issue: Proceedings from Vitamin C as Cancer Therapy Workshop, Montreal. 15(4): 201-13. 1999.
145. Riordan N et al. Intravenous ascorbate as a tumour cytotoxic chemotherapeutic agent. Medical Hypothesis. 9(2): 207-13. 1994.
146. Benade L, Howard T and Burke D. Synergistic killings of Ehrlich ascites carcinoma cells by ascorbate and 3 amino-1, 2, 4-triazole. Oncology. 1969;23:33-43.
147. Tsao C, Dungham B and Ping Y. In vivo antineoplastic activity of ascorbic acid for human mammary tumour. In vivo. 2: 147-50. 1988.
148. Bram S et al. Vitamin C preferential toxicity for malignant melanoma cells. Nature. 284: 629-31. 1980.
149. Matsuda, T., Kuroyanagi, M., Sugiyama, S., Umehara, K., Ueno, A. and Nishi, K. Role of hydrogen peroxide for cell death induction by sodium 5,6-Benzylidene-L-ascorbate. Chem Pharm Bull 1994; 6: 1216-1225.
150. Agus DB, Vera JC and Golde DW. Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Research. 1999;59:4555-4558.
151. Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, and Levine L. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. PNAS. September 20, 2005. Vol. 102. No. 38. pp. 13604-13609.
152. Maramag C et al. Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis. Prostate. 32: 188-95. 1997.
153. Ha YM, Park MK, Kim HJ, Seo HG, Lee JH, Chang KC. High concentrations of ascorbic acid induces apoptosis of human gastric cancer cell by p38-MAP kinase-dependent up-regulation of transferrin receptor. Cancer Lett. 2009 May 8;277(1):48-54.
154. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and Fas ligand expression. J Exp Med 195(1):59-70, 2002.
155. Williams MS, Kwon J. T cell receptor stimulation, reactive oxygen species and cell signaling. Free Rad Biol Med 37(8):1144-1151, 2004.
156. Wentworth et al., 2000) (Wentworth AD, Jones LH, Wentworth P Jr, Janda KD, Lerner RA. Antibodies have the intrinsic capacity to destroy antigens. PNAS 97(20):10930-10935, 2000).
157. Wentworth P Jr, Jones LH, Wentworth AD, Zhu X, Larsen NA, Wilson IA, Xu X, Goddard WA III, Janda KD, Eschenmoser A, Lerner RA. Antibody catalysis of the oxidation of water. Science 293 (5536):1806-1811, 2001.
158. Wentworth P Jr, Wentworth AD, Zhu X, Wislon IA, Janda KD, Eschenmoser A, Lerner RA. Evidence for the production of trioxygen species during antibody-catalyzed chemical modification of antigens. PNAS 100(4):1490-1493, 2003.
159. IARC. 1985. International Agency for Research on Cancer. Hydrogen Peroxide. In: IARC Monographs on the Evaluation of Carcinogenic Risk if Chemicals to Humans: Allyl compounds, Aldehydes, Epoxides and Peroxides, Vol. 36. IARC, Lyon, pp. 285-314.
160. Cina SJ, Downs JC, Conradi SE. Hydrogen peroxide: a source of lethal oxygen embolism. Case report and review of the literature. Am J Forensic Med Pathol. 1994 Mar;15(1):44-50.
161. Starfield, B. Is US Health Really the Best in the World? JAMA 2000 Jul 26;284[4]:483-5.
162. Jay Pravda. Radical induction theory of ulcerative colitis. J Gastroenterol April 28, 2005 April;11(16):2371-2384.
163. Dickson KF, Caravati EM. Abstract: Hydrogen peroxide exposure--325 exposures reported to a regional poison control center. J Toxicol Clin Toxicol. 1994;32(6):705-14.
164. Howes, R. M. U.T.O.P.I.A. - Unified Theory of Oxygen Participation in Aerobiosis. © 2004. Free Radical Publishing Co. Kentwood, LA Available at www.iwillfindthecure.org.
165. Kroemer, G., Zamzami, N. and Susin, S.A. Mitochondrial control of apoptosis. Immunol Today 1997; 18: 44-51.
166. Fleury C, Mignotte B, Vayssiere JL Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002;84:131-41.
167. Mansat-de Mas V, Bezombes C, Quillet-Mary A, et al Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin. Mol Pharmacol 1999;56:867-74.
168. Simizu S, Umezawa K, Takada M, Arber N, Imoto M Induction of hydrogen peroxide production and Bax expression by caspase-3(-like) proteases in tyrosine kinase inhibitor-induced apoptosis in human small cell lung carcinoma cells. Exp Cell Res 1998;238:197-203.
169. Hirpara JL, Clement MV, Pervaiz S Intracellular acidification triggered by mitochondrial-derived hydrogen peroxide is an effector mechanism for drug-induced apoptosis in tumor cells. J Biol Chem 2001;276:514-21.
170. Clement MV, Ponton A, Pervaiz S Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu. FEBS Lett 1998;440:13-18.
171. Kerr, J.F.R., Winterfold, C.M. and Harmon, B.V. Apoptosis, its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-2026.
172. Blackstone, N.W. and Green, D.R. The evolution of a mechanism of cell suicide. Bio Essays 1999; 21: 84-88.
173. Khyshiktyev BS, Khyshiktueva NA, Ivanov VN, Darenskaia SD, Novikov SV. Diagnostic value of investigating exhaled air condensate in lung cancer. Vopr Onkol 1994; 40: 161-164.
174. Tsujimoto Y., Shimizu S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ., 7: 1174-1181, 2000.
175. Korsmeyer S. J. BCL-2 gene family and the regulation of programmed cell death. Cancer Res., 59: 1693-1700S, 1999.
176. Harris M. H., Thompson C. B. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ, 7: 1182-1191, 2000.
177. Clement M. V., Pervaiz S. Reactive oxygen intermediates regulate cellular response to apoptotic stimuli: an hypothesis. Free Radic. Res., 30: 247-252, 1999.
178. Clement M. V., Pervaiz S. Intracellular superoxide and hydrogen peroxide concentrations: a critical balance that determines survival or death. Redox. Rep., 6: 211-214, 2001.
179. Pervaiz S., Clement M. V. Hydrogen peroxide-induced apoptosis: oxidative or reductive stress?. Methods Enzymol., 352: 150-159, 2002.
180. Pervaiz S., Clement M. V. A permissive apoptotic environment: function of a decrease in intracellular superoxide anion and cytosolic acidification. Biochem. Biophys. Res. Commun., 290: 1145-1150, 2002.
181. Fleury C, Mignotte B, Vayssiere JL Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002;84:131-41.
182. Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res 2002;62:4592-8.
183. Quillet-Mary A, Jaffrezou JP, Mansat V, Bordier C, Naval J, Laurent G Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 1997;272:21388-95.
184. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B Role of BAX in the apoptotic response to anticancer agents. Science 2000;290:989-92.
185. Hug H, Strand S, Grambihler A, et al Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem 1997;272:28191-3.
186. Suhara T, Fukuo K, Sugimoto T, et al Hydrogen peroxide induces up-regulation of Fas in human endothelial cells. J Immunol 1998;160:4042-7.
187. Hirpara JL, Clement MV, Pervaiz S. Intracellular acidification triggered by mitochondrial-derived hydrogen peroxide is an effector mechanism for drug-induced apoptosis in tumor cells. J Biol Chem 2001;276:514-21.
188. Ahmad KA, Clement MV, Hanif IM, Pervaiz S. Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution. Cancer Res 2004;64:1452-9.
189. Cerutti P. A. Prooxidant states and tumor promotion. Science (Wash. DC), 227: 375-381, 1985.
190. Burdon R. H., Gill V., Rice-Evans C. Oxidative stress and tumour cell proliferation. Free Radic. Res. Commun., 11: 65-76, 1990.
191. Fadeel B., Ahlin A., Henter J. I., Orrenius S., Hampton M. B. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood, 92: 4808-4818, 1998.
192. Hampton M. B., Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett., 414: 552-556, 1997.
193. Tze Wei Poh and Shazib Pervaiz. LY294002 and LY303511 Sensitize Tumor Cells to Drug-Induced Apoptosis via Intracellular Hydrogen Peroxide Production Independent of the Phosphoinositide 3-Kinase-Akt Pathway. Cancer Research 65, 6264-6274, July 15, 2005.
194. Cullen, J. J., Hinkhouse, M. M., Grady, M., Gaut, A. W., Liu, J., Zhang, Y., Weydert, C. J. D., Domann, F. E., and Oberley, L. W. (2003) Cancer Res. 63, 5513–5520.
195. Juan Du, David H. Daniels, Carla Asbury, Sujatha Venkataraman, Jingru Liu, Douglas R. Spitz, Larry W. Oberley, and Joseph J. Cullen. Mitochondrial Production of Reactive Oxygen Species Mediate Dicumarol-induced Cytotoxicity in Cancer Cells. The Journal of Biological Chemistry Vol. 281, No. 49, pp. 37416–37426, December 8, 2006.
196. Sun Wenqing; Kalen Amanda L; Smith Brian J; Cullen Joseph J; Oberley Larry W. Enhancing the antitumor activity of adriamycin and ionizing radiation. Cancer research 2009;69(10):4294-300.
197. Wagner B A; Buettner G R; Oberley L W; Darby C J; Burns C P. Myeloperoxidase is involved in H2O2-induced apoptosis of HL-60 human leukemia cells. The Journal of biological chemistry 2000;275(29):22461-9.
198. Jun Fang, Tomohiro Sawa, Takaaki Akaike and Hiroshi Maeda. Tumor-targeted Delivery of Polyethylene Glycol-conjugated D-Amino Acid Oxidase for Antitumor Therapy via Enzymatic Generation of Hydrogen Peroxide. Cancer Research 62, 3138-3143, June 1, 2002.
199. Venkataraman Sujatha; Jiang Xiaohong; Weydert Christine; Zhang Yuping; Zhang Hannah J; Goswami Prabhat C; Ritchie Justine M; Oberley Larry W; Buettner Garry R. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 2005;24(1):77-89.
200. Aykin-Burns Nùkhet; Ahmad Iman M; Zhu Yueming; Oberley Larry W; Spitz Douglas R. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. The Biochemical Journal 2009;418(1):29-37.
201. Yoshizaki K, et al. Pro-senescent effect of hydrogen peroxide on cancer cells and its possible application to tumor suppression. Biosci Biotechnol Biochem. 2009 Feb;73(2):311-5.
202. Brian D. Lawenda, Kara M. Kelly, Elena J. Ladas, Stephen M. Sagar, Andrew Vickers, Jeffrey B. Blumberg. Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy? JNCI Journal of the National Cancer Institute 2008 100(11):773-783.
203. Vicki Brower. An Apple a Day May Be Safer Than Vitamins. JNCI Journal of the National Cancer Institute 2008 100(11):770-772.
204. Howes M.D., PhD., R. (2009). Dangers of Antioxidants in Cancer Patients: A Review. PHILICA.COM Article number 153. Published 7th February, 2009.
205. Nima Sharifi. Commentary: Antioxidants for Cancer: New Tricks for an Old Dog? The Oncologist, Vol. 14, No. 3, 213-215, March 2009.
206. Salganik, R. I., Albright, C. D., Rodgers, J., Kim, J., Zeisel, S. H., Sivashinskiy, M. S. & Van Dyke, T. A. (2000) Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. Carcinogenesis 21: 909–914.
Generated at: Sun, 20 Jan 2013 08:31:16 -0600 (000002da) — http://www.ispub.com:80/journal/the-internet-journal-of-plastic-surgery/volume-7-number-1/hydrogen-peroxide-a-review-of-a-scientifically-verifiable-omnipresent-ubiquitous-essentiality-of-obligate-aerobic-carbon-based-life-forms.html - See more at: http://www.ispub.com/journal/the-internet-journal-of-plastic-surgery/volume-7-number-1/hydrogen-peroxide-a-review-of-a-scientifically-verifiable-omnipresent-ubiquitous-essentiality-of-obligate-aerobic-carbon-based-life-forms.html#sthash.9hVZUjqH.n4YJ1P4w.dpuf